Literature DB >> 28455576

[Pathogenesis of urinary tract infections : An update].

G Magistro1, J Marcon2, S Schubert3, C Gratzke2, C G Stief2.   

Abstract

Urinary tract infections are among the most common bacterial infections worldwide. The management has become a public health concern of socioeconomic importance. Every second woman will experience at least one episode in her lifetime. Due to the emergence of multiresistant pathogens and the developmental void, treatment has become more challenging over the years. Deciphering the complex molecular interaction between host and pathogen is necessary to identify potent treatment targets for future approaches. The objective of this review is to present novel aspects on the pathogenesis of urinary tract infections and its relevance for clinical practice.

Entities:  

Keywords:  Antibiotics; Bacteriuria; Intracellular bacterial communities; Urinary tract; Virulence factors

Mesh:

Year:  2017        PMID: 28455576     DOI: 10.1007/s00120-017-0391-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  68 in total

Review 1.  Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

2.  First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).

Authors:  Andreas Wieser; Giuseppe Magistro; Dominik Nörenberg; Christiane Hoffmann; Sören Schubert
Journal:  Int J Med Microbiol       Date:  2011-10-13       Impact factor: 3.473

3.  Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

Review 4.  Host subversion by formation of intracellular bacterial communities in the urinary tract.

Authors:  Gregory G Anderson; Steven M Martin; Scott J Hultgren
Journal:  Microbes Infect       Date:  2004-10       Impact factor: 2.700

5.  Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.

Authors:  Karen L Mossman; M Firoz Mian; Nicole M Lauzon; Carlton L Gyles; Brian Lichty; Randy Mackenzie; Navkiran Gill; Ali A Ashkar
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

Authors:  Bryndís Ragnarsdóttir; Klas Jönsson; Alexander Urbano; Jenny Grönberg-Hernandez; Nataliya Lutay; Martti Tammi; Mattias Gustafsson; Ann-Charlotte Lundstedt; Irene Leijonhufvud; Diana Karpman; Björn Wullt; Lennart Truedsson; Ulf Jodal; Björn Andersson; Catharina Svanborg
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

7.  Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.

Authors:  Bryndís Ragnarsdóttir; Martin Samuelsson; Mattias C U Gustafsson; Irene Leijonhufvud; Diana Karpman; Catharina Svanborg
Journal:  J Infect Dis       Date:  2007-06-21       Impact factor: 5.226

Review 8.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

9.  Host imprints on bacterial genomes--rapid, divergent evolution in individual patients.

Authors:  Jaroslaw Zdziarski; Elzbieta Brzuszkiewicz; Björn Wullt; Heiko Liesegang; Dvora Biran; Birgit Voigt; Jenny Grönberg-Hernandez; Bryndis Ragnarsdottir; Michael Hecker; Eliora Z Ron; Rolf Daniel; Gerhard Gottschalk; Jörg Hacker; Catharina Svanborg; Ulrich Dobrindt
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.

Authors:  Jeongmin Song; Matthew J Duncan; Guojie Li; Cheryl Chan; Richard Grady; Ann Stapleton; Soman N Abraham
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.